Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phase II Evaluation of Gemcitabine Monotherapy for Cutaneous T-Cell Lymphoma
Madeleine Duvic, Rakhshandra Talpur, Sijin Wen, et al.
Clinical Lymphoma & Myeloma (2006) Vol. 7, Iss. 1, pp. 51-58
Closed Access | Times Cited: 150

Showing 26-50 of 150 citing articles:

Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Peripheral T-cell lymphomas
Pier Luigi Zinzani, Vijayveer Bonthapally, Dirk Huebner, et al.
Critical Reviews in Oncology/Hematology (2016) Vol. 99, pp. 214-227
Open Access | Times Cited: 47
Total Skin Electron Beam Therapy in the Treatment of Mycosis Fungoides: A Review of Conventional and Low-Dose Regimens
Mudit Chowdhary, Arpit M. Chhabra, Shivam M. Kharod, et al.
Clinical Lymphoma Myeloma & Leukemia (2016) Vol. 16, Iss. 12, pp. 662-671
Closed Access | Times Cited: 47
A retrospective comparative outcome analysis following systemic therapy in Mycosis fungoides and Sezary syndrome
Walter Hanel, Robert Briski, Charles W. Ross, et al.
American Journal of Hematology (2016) Vol. 91, Iss. 12
Open Access | Times Cited: 47
Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma
Adriana T. Lopez, Susan E. Bates, Larisa J. Geskin
American Journal of Clinical Dermatology (2018) Vol. 19, Iss. 6, pp. 805-819
Closed Access | Times Cited: 47
S2k‐Leitlinie – Kutane Lymphome (ICD10 C82–C86): Update 2021
Edgar Dippel, Chalid Assaf, Jürgen C. Becker, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2022) Vol. 20, Iss. 4, pp. 537-555
Open Access | Times Cited: 22
Gemcitabine treatment in cutaneous T-cell lymphoma: a multicentre study of 23 cases
Kaoutar Jidar, S. Oro, M. Beylot‐Barry, et al.
British Journal of Dermatology (2009) Vol. 161, Iss. 3, pp. 660-663
Closed Access | Times Cited: 61
Management of cutaneous T cell lymphoma: new and emerging targets and treatment options
Janet Y. Li, Steven Horwitz, Alison J. Moskowitz, et al.
Cancer Management and Research (2012), pp. 75-75
Open Access | Times Cited: 51
Systematic review of combination therapies for mycosis fungoides
Daniel Humme, Alexander Nast, R. Erdmann, et al.
Cancer Treatment Reviews (2014) Vol. 40, Iss. 8, pp. 927-933
Closed Access | Times Cited: 45
S2k Guidelines – Cutaneous Lymphomas Update 2016 – Part 2: Treatment and Follow‐up (ICD10 C82 ‐ C86)
Edgar Dippel, Chalid Assaf, Jürgen C. Becker, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2017) Vol. 16, Iss. 1, pp. 112-122
Open Access | Times Cited: 45
Advances in Novel Systemic Therapies for the Management of Cutaneous T Cell Lymphoma (CTCL)
Katherine Case, Pamela B. Allen
Current Hematologic Malignancy Reports (2025) Vol. 20, Iss. 1
Closed Access
Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma
Tim Illidge, Clara C. Chan, Nicholas Counsell, et al.
British Journal of Cancer (2013) Vol. 109, Iss. 10, pp. 2566-2573
Open Access | Times Cited: 39
T-cell lymphomas, a challenging disease: types, treatments, and future
Helen Ma, Maher Abdul‐Hay
International Journal of Clinical Oncology (2016) Vol. 22, Iss. 1, pp. 18-51
Open Access | Times Cited: 37
Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease
Lisa Argnani, Alessandro Broccoli, Pier Luigi Zinzani
Cancer Treatment Reviews (2017) Vol. 61, pp. 61-69
Closed Access | Times Cited: 34
Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas
Pier Luigi Zinzani, Vijayveer Bonthapally, Dirk Huebner, et al.
Critical Reviews in Oncology/Hematology (2016) Vol. 99, pp. 228-240
Open Access | Times Cited: 32
Gemcitabine, oxaliplatin and dexamethasone as salvage treatment for elderly patients with refractory and relapsed peripheral T-cell lymphoma
Yiyun Yao, Yong Tang, Qi Zhu, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2012) Vol. 54, Iss. 6, pp. 1194-1200
Closed Access | Times Cited: 36
Brief S2k guidelines – Cutaneous lymphomas
Rudolf Stadler, Chalid Assaf, Claus‐Detlev Klemke, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2013) Vol. 11, Iss. s3, pp. 19-28
Closed Access | Times Cited: 33
Interferon and Low Dose Methotrexate Improve Outcome in Refractory Mycosis Fungoides/Sézary Syndrome
Agustín Avilés, M. Jesús Nambo, Natividad Neri, et al.
Cancer Biotherapy and Radiopharmaceuticals (2007) Vol. 22, Iss. 6, pp. 836-840
Closed Access | Times Cited: 40
Cutaneous T-cell Lymphoma
Frederick Lansigan, Jaehyuk Choi, Francine M. Foss
Hematology/Oncology Clinics of North America (2008) Vol. 22, Iss. 5, pp. 979-996
Closed Access | Times Cited: 37
The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications
Ercole Mazzeo, Laura Rubino, Michela Buglione, et al.
Reports of Practical Oncology & Radiotherapy (2013) Vol. 19, Iss. 2, pp. 77-91
Open Access | Times Cited: 29
Cutaneous T cell Lymphoma: an Update on Pathogenesis and Systemic Therapy
Catherine Chung, Brian Poligone
Current Hematologic Malignancy Reports (2015) Vol. 10, Iss. 4, pp. 468-476
Closed Access | Times Cited: 28
Gemcitabine-induced cardiomyopathy: a case report and review of the literature
Muhammad Fahad Khan, Silvija P. Gottesman, Ravichandra Boyella, et al.
Journal of Medical Case Reports (2014) Vol. 8, Iss. 1
Open Access | Times Cited: 25
Suggested Guidelines for the Treatment of Mycosis Fungoides in Countries with Limited Resources
Mona Abdel-Halim Ibrahim, Nada Eltayeb, Mirna Michel Ibrahim, et al.
Dermatology Research and Practice (2023) Vol. 2023, pp. 1-16
Open Access | Times Cited: 7
Advances in the treatment of mycoses fungoides and Sézary syndrome: a narrative update in skin-directed therapies and immune-based treatments
Robert Stuver, Shamir Geller
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Gemcitabine-Related "Pseudocellulitis": Report of 2 Cases and Review of the Literature
Darrell H. S. Tan, Paul E. Bunce, W. Conrad Liles, et al.
Clinical Infectious Diseases (2007) Vol. 45, Iss. 5, pp. e72-e76
Open Access | Times Cited: 35
Novel Therapies for Cutaneous T-Cell Lymphomas
Sarah McCue Horwitz
Clinical Lymphoma & Myeloma (2008) Vol. 8, pp. S187-S192
Closed Access | Times Cited: 32

Scroll to top